Author/Authors :
Stankovic، نويسنده , , Goran and Chieffo، نويسنده , , Alaide and Iakovou، نويسنده , , Ioannis and Orlic، نويسنده , , Dejan and Corvaja، نويسنده , , Nicola and Sangiorgi، نويسنده , , Giuseppe and Airoldi، نويسنده , , Flavio and Colombo، نويسنده , , Antonio، نويسنده ,
Abstract :
We evaluated predictors of increased periprocedural creatine kinase-MB isoenzyme levels after implantation of sirolimus-eluting stents with an intent to fully cover the diseased segment. The total stent length per patient (predisposing factor) and elective use of glycoprotein IIb/IIIa (protective factor) were independent predictors of increased creatine kinase-MB isoenzyme levels.
